Authors
Latest:
Nivolumab/Ipilimumab Extends Survival in First-Line MSI-H/dMMR Metastatic Colorectal CancerUpdated results from the phase 3 CheckMate-8HW trial continue to show fewer severe (grade 3/4) side effects with nivolumab/ipilimumab compared to chemotherapy.
Latest:
Nina Kadan-Lottick on Improving Survivorship Care PlansNina Kadan-Lottick, MD, associate professor of Pediatrics (Hematology/Oncology and medical director of the HEROES program at Yale School of Medicine, discusses ways to improve survivorship care plans.
Latest:
Nurses Are Crucial in the Myeloma Treatment TeamNurses play a key role in treating patients with myeloma.
Latest:
Eva Pendleton Discusses the Evidence Behind Integrative TherapiesEva Pendleton, LMT, manager, integrative health, Perlmutter Cancer Center at NYU Langone, discusses the evidence supporting the use of integrative therapies during a patient's cancer treatment.
Latest:
Brianna Hoffner Discusses Monitoring Adverse Events in Patients Receiving Treatment for MelanomaBrianna Hoffner, MSN, RN, ANP-BC, AOCNP, nurse practitioner, The Angeles Clinic and Research Institute, discusses how to monitor the adverse events in patients receiving treatment for melanoma.
Latest:
Team Up, Be Aggressive: Improving Outcomes for Metastatic Colon CancerThe management of patients with colorectal liver metastases is complicated and requires careful assessment from a multidisciplinary tumor board—especially in light of recent advances made with chemotherapy, according to Michael J. Cavnar, MD.
Latest:
Beyond BRCA: Gene Mutations in Breast CancerIn just over 5 years, the growth and development in the field of breast cancer have been astronomical. Julie Nangia, MD, Assistant Professor of Medicine, Baylor College of Medicine, discusses the recent explosion of knowledge about non-BRCA genes, and the significant progress in therapies targeted to BRCA mutation carriers.
Latest:
High-Touch Wipe Down: Decreasing C. diff Rates in Adults With CancerFollowing a high rate of CDIs, the inpatient medical oncology unit at the University of California, Los Angeles, Santa Monica Medical Center adapted an evidence-based intervention.
Latest:
Jenna Forsythe Discusses Challenges Faced by Patients With Leukemia and LymphomaJenna Forsythe, MSN, RN, OCN, a nurse in the leukemia and lymphoma outpatient center at John Theurer Cancer Center, discusses some of the challenges patients with leukemia and lymphoma face.
Latest:
Dr. Chlebowski on the Women's Intervention Nutrition Study (WINS)Rowan Chlebowski, MD, PhD, Professor and Chief, Harbor-UCLA Medical Center, Department of Internal Medicine, Medical Oncology/Hematology Member, Jonsson Comprehensive Cancer Center, discusses the results of the Women's Intervention Nutrition Study (WINS).
Latest:
Melissa Andres on the Role of the Nurse NavigatorMelissa Andres explains the role of the nurse navigator for patients with cancer.
Latest:
Suzanne Walker on Enhancing the End-of-Life Transition With FaceTimeSuzanne Walker, CRNP, MSN, AOCN, BC, University of Pennsylvania Health System, discusses a study looking at enhancing the end-of-life transition with FaceTime.
Latest:
Radiation Therapy in Early-Stage Breast Cancer: When Less Is MoreWomen diagnosed with early-stage breast disease have a variety of decisions to make regarding their treatment options. For example, some women may be eligible for breast-conserving surgery, which typically includes a lumpectomy followed by radiation.
Latest:
Gail Moore on Warning Signs of CardiotoxicityGail Moore, BSN, RN, OCN, discusses the warning signs of cardiotoxicity from chemotherapy that nurses and patients should be aware of.
Latest:
Maureen E. Thyne Discusses Ruxolitinib's Impact on MyelofibrosisMaureen E. Thyne, RPA-C, Weill Cornell Medical College, discusses the impact that ruxolitinib (Jakafi) has had on patients with myelofibrosis.
Latest:
Tricia Strusowski on the Importance of Nurse Navigators in Community Oncology SettingsTricia Strusowski, MS, RN, Oncology Solutions, discusses the importance of the nurse navigator role, especially in community oncology settings, at the 2017 ACCC Cancerscape meeting.
Latest:
Sustainability Strategies for NavigationNurse navigators should consider sustainability strategies to ensure that their progress remains.
Latest:
Kevin Oeffinger on the Importance of Cancer Survivorship in the Primary Care SettingKevin Oeffinger, MD, Director of the Cancer Survivorship Center at Memorial Sloan Kettering Cancer Center, discusses the importance of cancer survivorship in the primary care setting.
Latest:
Areej El-Jawahri on Patients' Misconceptions in Cancer CareAreej El-Jawahri, MD, an oncologist at Massachusetts General Hospital, discusses how patients with cancer do not often have a full understanding of the terms and processes doctors describe during treatment.
Latest:
Once Again, Laughter Is Still Good MedicineAs those of us immersed in our roles as oncology nurse navigators know only too well, each day holds the potential to be filled with unexpected
Latest:
Serving Up Inspiration: Nurse Brings Bedside Expertise to the BoardroomRegina Cunningham discusses her path from oncology nurse to hospital system CEO and shares insights on how nurses can leverage their unique skills to assume leadership roles.
Latest:
Real-World Data Verify Safety, Efficacy of Dostarlimab/Chemo in Endometrial CancerThe safety and efficacy of dostarlimab plus chemotherapy in patients with advanced endometrial cancer were confirmed by results of a real-world study.
Latest:
Practice Pearls for Toxicity Management With ADC Therapy in Breast and Gastric CancerShared practical advice on the management of toxicities associated with antibody drug conjugate therapy in both the breast cancer and GI cancer settings.
Latest:
Breaking Down the Barriers: Tackling Patient Recruitment Challenges in Clinical TrialsPatients fear being a "guinea pig" or receiving a placebo, healthcare providers do not have time to keep up with all of the clinical trial information or talk with patients in depth, conducting clinical trials is very expensive for healthcare systems, and funding continues to decline for research
Latest:
It Takes a Team: Treating Adverse EventsA multidisciplinary care team is needed when treating patients who are given a combination of chemotherapy and immunotherapy.
